| Trademark Snap Shot ITU Unit Action (Table presents the data on ITU Unit Action) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 88130645 | FILING DATE | 09/25/2018 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | KUNKLEMAN, SARAH E |
L.O. ASSIGNED | 105 |
PUB INFORMATION |
|||
| RUN DATE | 04/17/2021 | ||
| PUB DATE | 09/03/2019 | ||
| STATUS | 732-THIRD EXTENSION - GRANTED | ||
| STATUS DATE | 04/15/2021 | ||
| LITERAL MARK ELEMENT | TIVDAK | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | YES |
| LITERAL MARK ELEMENT | TIVDAK |
| MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 21-SUBSEQUENT OWNER AFTER PUBLICATION |
| NAME | SEAGEN INC. |
| ADDRESS | 21823 30TH DRIVE S.E. BOTHELL, WA 98021 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Delaware |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Pharmaceutical preparations for use in humans, namely, chemotherapeutics and biopharmaceuticals for the treatment of diseases and conditions; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology, ophthalmology, gastroenterological disorders, and tissue and organ transplantology |
| INTERNATIONAL CLASS | 042 |
| DESCRIPTION TEXT | Biotechnology research, namely, research and development of pharmaceutical preparations for use in humans; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of cancer, autoimmune diseases, inflammatory disorders, gastroenterological disorders and for use in dermatology, oncology, hematology, ophthalmology, and tissue and organ transplantation |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 042 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 04/17/2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 032 |
| 04/15/2021 | EX3G | S | EXTENSION 3 GRANTED | 031 |
| 04/15/2021 | EXT3 | S | EXTENSION 3 FILED | 030 |
| 04/15/2021 | EEXT | I | TEAS EXTENSION RECEIVED | 029 |
| 01/13/2021 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 028 |
| 09/29/2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 027 |
| 09/25/2020 | EX2G | S | EXTENSION 2 GRANTED | 026 |
| 09/25/2020 | EXT2 | S | EXTENSION 2 FILED | 025 |
| 09/25/2020 | EEXT | I | TEAS EXTENSION RECEIVED | 024 |
| 08/13/2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | 023 |
| 08/13/2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 022 |
| 08/13/2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 021 |
| 04/07/2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 020 |
| 04/03/2020 | EX1G | S | EXTENSION 1 GRANTED | 019 |
| 04/03/2020 | EXT1 | S | EXTENSION 1 FILED | 018 |
| 04/03/2020 | EEXT | I | TEAS EXTENSION RECEIVED | 017 |
| 11/12/2019 | DOCK | D | ASSIGNED TO EXAMINER | 016 |
| 10/29/2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 015 |
| 09/03/2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 014 |
| 09/03/2019 | PUBO | A | PUBLISHED FOR OPPOSITION | 013 |
| 08/14/2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 012 |
| 07/31/2019 | ALIE | A | ASSIGNED TO LIE | 011 |
| 07/24/2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 010 |
| 07/04/2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 009 |
| 07/03/2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 008 |
| 07/03/2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 007 |
| 01/08/2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 006 |
| 01/08/2019 | GNRT | F | NON-FINAL ACTION E-MAILED | 005 |
| 01/08/2019 | CNRT | R | NON-FINAL ACTION WRITTEN | 004 |
| 01/07/2019 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
| 10/02/2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 09/28/2018 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Harold Milstein |
| CORRESPONDENCE ADDRESS | Harold Milstein Sheppard Mullin Richter & Hampton LLP 379 Lytton Avenue Palo Alto CA 94301 |
| DOMESTIC REPRESENTATIVE | NONE |
PRIOR OWNER INFORMATION |
|
| PARTY TYPE | 20-OWNER AT PUBLICATION |
| NAME | Seattle Genetics, Inc. |
| ADDRESS | 21823 30th Drive S.E. Bothell, WA 98021 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Delaware |
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Seattle Genetics, Inc. |
| ADDRESS | 21823 30th Drive S.E. Bothell, WA 98021 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Delaware |